Is Procter & Gamble Stock Underperforming the Nasdaq?
Valued at a market cap of $343.4 billion, The Procter & Gamble Company (PG) is one of the world's largest consumer goods companies, selling a broad portfolio of everyday household, personal care, health, beauty, and grooming products in about 180 countries and territories. The Cincinnati, Ohio-based company has built its business around globally recognized brands such as Tide, Pampers, Gillette, Head & Shoulders, Pantene, Olay, Oral-B, Always, Dawn, Bounty, and Crest.
Companies worth $200 billion or more are typically classified as "mega-cap stocks," and PG fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the household & personal products industry. The company's scale, powerful brands, extensive distribution network, and consistent product innovation give it a formidable position in the global fast-moving consumer goods industry.
Jeff Bezos' Heartfelt Tribute to Dolly Parton Drew Brutal Backlash: 'Nobody Wanted to Hear This From You', He Once Gave Her $100 Million for Charity
A $100 Billion Buildout In Louisiana Is Planned for Starship. What This Means for SPCX Stock.
Despite its notable strength, this personal care company has dipped 14.2% from its 52-week high of $167.25, reached on Feb. 27. Moreover, shares of PG have fallen 1.6% over the past three months, notably underperforming the Nasdaq Composite's ($NASX) 2% fall during the same time frame.
In the longer term, PG has declined 7.8% over the past 52 weeks, lagging NASX's 21.6% uptick over the same time period. Moreover, on a YTD basis, shares of PG are up marginally, compared to the index's 13.6% rise.
To confirm its bearish trend, PG has been trading below its 200-day moving average since mid-March. However, it has recently started trading above its 50-day moving average since late May.
On Aug. 4, PG shares jumped 2.1% after the company announced a definitive agreement to acquire Thorne, a science-backed health and wellness company, from L Catterton's Flagship Fund. The acquisition marks an important expansion of P&G's Personal Health Care business, strengthening its foothold in the fast-growing premium wellness and personalized health markets.
In the competitive arena of household & personal products, Colgate-Palmolive Company (CL) has taken the lead over PG, with its shares rising 8.9% over the past 52 weeks and growing 15% on a YTD basis.
Despite PG's recent underperformance, analysts remain moderately optimistic about its prospects. The stock has a consensus rating of "Moderate Buy" from the 26 analysts covering it, and the mean price target of $160.58 suggests a 11.7% premium to its current price levels.
